New drug takes first step in fight against high blood pressure
Disease control
Completed
This early-stage study tested a new experimental drug called SGB-3908 for high blood pressure. Researchers gave single doses to 40 healthy volunteers and people with mild hypertension to check if it's safe and how the body processes it. The main goal was to see what side effects …
Phase: PHASE1 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC